Literature DB >> 25910994

Does the use of an acellular dermal graft in abdominal closure after rectus flap harvest impact the occurrence of post-operative hernia?

Masoud Saman1, Sameep Kadakia2, Yadranko Ducic3,4,5.   

Abstract

IMPORTANCE: Patients with rectus free flap harvest extending below the arcuate line are predisposed to postoperative hernia formation. As such, many authors have advocated the use of closure adjuncts to increase the integrity of the closure and prevent hernia or abdominal wall bulging.
SETTING: Busy level 1 public trauma center in metropolitan Fort Worth, Texas
INTERVENTIONS: Following harvest of the rectus free flap, 48 patients underwent primary closure; 24 of these patients had defects extending below the arcuate line. Forty patients were closed with an acellular dermal graft; 22 of these patients had defects extending below the arcuate line. MAIN OUTCOME MEASURE: Postoperative hernia formation and local infection rate were examined in a minimum follow-up period of 1 year.
RESULTS: Regardless of closure method, no hernias were observed in the postoperative period. Using an unpaired t test and an alpha value of 0.05, there was no statistically significant difference in the infection rate between the two groups.
CONCLUSION: Following rectus abdominis myocutaneous free flap harvest, the use of an acellular dermal graft in abdominal wall closure may not be of any further advantage in the prevention of hernia. LEVEL OF EVIDENCE: Retrospective (Level III).

Entities:  

Keywords:  Acellular dermal graft; Arcuate; Flap; Hernia; Rectus

Mesh:

Year:  2015        PMID: 25910994     DOI: 10.1007/s10006-015-0498-1

Source DB:  PubMed          Journal:  Oral Maxillofac Surg        ISSN: 1865-1550


  24 in total

1.  Use of an acellular dermal allograft for dural replacement: an experimental study.

Authors:  J M Chaplin; P D Costantino; M E Wolpoe; J B Bederson; E S Griffey; W X Zhang
Journal:  Neurosurgery       Date:  1999-08       Impact factor: 4.654

2.  Early results of vermilion lip augmentation using acellular allogeneic dermis: an adjunct in facial rejuvenation.

Authors:  R J Rohrich; B J Reagan; W P Adams; J M Kenkel; S J Beran
Journal:  Plast Reconstr Surg       Date:  2000-01       Impact factor: 4.730

3.  AlloDerm for dorsal nasal irregularities.

Authors:  I T Jackson; R Yavuzer
Journal:  Plast Reconstr Surg       Date:  2001-02       Impact factor: 4.730

4.  Transverse abdominal flaps and the deep epigastric arcade.

Authors:  R G Brown; L O Vasconez; M J Jurkiewicz
Journal:  Plast Reconstr Surg       Date:  1975-04       Impact factor: 4.730

5.  Abdominal complications and sequelae after breast reconstruction with pedicled TRAM flap: is there still an indication for pedicled TRAM in the year 2003?

Authors:  Jean Y Petit; Mario Rietjens; Cristina Garusi; Andrea Giraldo; Francesca De Lorenzi; Piercarlo Rey; Edoardo C Millen; Barbara Pace da Silva; Riccardo Bosco; Omar Youssef
Journal:  Plast Reconstr Surg       Date:  2003-09-15       Impact factor: 4.730

6.  Magnetic resonance imaging of micronized dermal graft in the larynx.

Authors:  Gul Moonis; Orville Dyce; Laurie A Loevner; Natasha Mirza
Journal:  Ann Otol Rhinol Laryngol       Date:  2005-08       Impact factor: 1.547

7.  Gore-Tex patch repair of the anterior rectus sheath in free rectus abdominis muscle and myocutaneous flaps.

Authors:  D G Pennington; T Lam
Journal:  Plast Reconstr Surg       Date:  1996-06       Impact factor: 4.730

8.  The external oblique flap for reconstruction of the rectus sheath.

Authors:  S L Spear; R K Walker
Journal:  Plast Reconstr Surg       Date:  1992-10       Impact factor: 4.730

9.  TRAM flap anatomy correlated with a 10-year clinical experience with 556 patients.

Authors:  P A Watterson; J Bostwick; T R Hester; J T Bried; G I Taylor
Journal:  Plast Reconstr Surg       Date:  1995-06       Impact factor: 4.730

10.  Closure of the donor defect for breast reconstruction with rectus abdominis myocutaneous flaps.

Authors:  J M Drever; N Hodson-Walker
Journal:  Plast Reconstr Surg       Date:  1985-10       Impact factor: 4.730

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.